- ···
- ···
- Data & APIs
- ···
- Events
- ···
- Marketfy
- ···
- Premarket Prep
- ···
- ···
- Join
- ···
- Login
- ···
- Contribute
- ···
Recent Quotes
You have no recent quotes
Range
70.2 - 70.67
Vol / Avg.
689.5K/770.5K
Div / Yield
0.11/0.16%
52 Wk
54.51 - 76.53
Mkt Cap
35.2B
Payout Ratio
-
Open
70.59
P/E
-
EPS
0.19
Shares
499.7M
Outstanding
499.7M
Total Float
-
Benzinga - May 6, 2021, 7:27AM
Benzinga - May 5, 2021, 7:08AM
Benzinga - May 4, 2021, 5:25PM
Benzinga - Apr 28, 2021, 5:19PM
Benzinga - Apr 28, 2021, 9:34AM
Benzinga - Mar 25, 2021, 9:11AM
Benzinga - Mar 22, 2021, 7:25AM
Benzinga - Mar 22, 2021, 6:48AM
Benzinga - Feb 25, 2021, 8:40AM
Benzinga - Feb 25, 2021, 7:45AM
Benzinga - Feb 23, 2021, 4:37PM
Benzinga - Dec 15, 2020, 11:15AM
Benzinga - Nov 13, 2020, 8:35AM
Benzinga - Nov 12, 2020, 7:54AM
Benzinga - Nov 12, 2020, 4:58AM
Benzinga - Nov 11, 2020, 6:43AM
load more
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Earnings
see more| Q2 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-08-17 | ||||||
| REV | |||||||
| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | 0.450 | 0.490 | 0.0400 | ||||
| REV | 1.920B | 1.910B | -10.000M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Price | Change | Chg % | Mkt Cap | |
|---|---|---|---|---|---|---|
| ALC | Alcon | 70.44 | 0.29 | 0.41% | 35.2B |
Alcon Frequently Asked Questions
Q
How do I buy Alcon (ALC) stock?
A
You can purchase shares of Alcon (NYSE: ALC) through any online brokerage.
Q
Who are Alcon's (ALC) competitors?
A
There are no as such competitors for Alcon.
Q
What is the target price for Alcon (ALC) stock?
A
The latest price target for Alcon (NYSE: ALC) was reported by Citigroup on May 6, 2021. The analyst firm set a price target for 72.00 expecting ALC to rise to within 12 months (a possible 2.21% upside). 12 analyst firms have reported ratings in the last year.
Q
Current Stock Price for Alcon (ALC)?
A
The stock price for Alcon (NYSE: ALC) is $70.44 last updated Fri Jun 11 2021 19:59:58 GMT+0000 (Coordinated Universal Time).
Q
Does Alcon (ALC) pay a dividend?
A
There are no upcoming dividends for Alcon.
Q
When is Alcon (NYSE:ALC) reporting earnings?
A
Alcon’s Q2 earnings are confirmed for after-market on August 17, 2021.
Q
Is Alcon (ALC) going to split?
A
There is no upcoming split for Alcon.
Q
What sector and industry does Alcon (ALC) operate in?
A
Alcon is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.